A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design

A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design

Abstract Background Total mesorectal excision is the standard surgical treatment for mid- and low-rectal cancer. Laparoscopy represents a clear leap forward in the management of rectal cancer patients, offering significant improvements in post-operative measures such as pain, first bowel movement, a...

Full description

Bibliographic Details
Main Authors: Bernard Lelong, Cécile de Chaisemartin, Helene Meillat, Sandra Cournier, Jean Marie Boher, Dominique Genre, Mehdi Karoui, Jean Jacques Tuech, Jean Robert Delpero, the French Research Group of Rectal Cancer Surgery (GRECCAR)
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Cancer
Subjects:
Rectal cancer
Minimally invasive
Transanal approach
Online Access:http://link.springer.com/article/10.1186/s12885-017-3200-1

Internet

http://link.springer.com/article/10.1186/s12885-017-3200-1

Similar Items